Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39976417

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2025 Feb 20
First author
Brown JR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Jun 5;392(21):2180-2181. doi: 10.1056/NEJMc2503839.
    note
    Source null
    related pmid
    40466081
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Jun 5;392(21):2181. doi: 10.1056/NEJMc2503839.
    note
    Source null
    related pmid
    40466082
    relationship
    Comment in

Authors and identifiers

  1. name
    Brown JR
    type
    Author
  2. name
    Seymour JF
    type
    Author
  3. name
    Jurczak W
    type
    Author
  4. name
    Aw A
    type
    Author
  5. name
    Wach M
    type
    Author
  6. name
    Illes A
    type
    Author
  7. name
    Tedeschi A
    type
    Author
  8. name
    Owen C
    type
    Author
  9. name
    Skarbnik A
    type
    Author
  10. name
    Lysak D
    type
    Author
  11. name
    Eom KS
    type
    Author
  12. name
    Šimkovič M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Brown JR
    type
    Author
  2. name
    Seymour JF
    type
    Author
  3. name
    Jurczak W
    type
    Author
  4. name
    Aw A
    type
    Author
  5. name
    Wach M
    type
    Author
  6. name
    Illes A
    type
    Author
  7. name
    Tedeschi A
    type
    Author
  8. name
    Owen C
    type
    Author
  9. name
    Skarbnik A
    type
    Author
  10. name
    Lysak D
    type
    Author
  11. name
    Eom KS
    type
    Author
  12. name
    Šimkovič M
    type
    Author
bibliography ids
  1. nci-bib-8feb3a0d9c5bf28a70e8adbc
book metadata
content sha256
97820814b34301c26944c6ebf60883ea3af4204e1332b5c250e1901ec0ac6fdb
document type
citation
dois
  1. 10.1056/NEJMoa2409804
electronic publication date
display
2025 Feb 5
precision
day
year
2025
evidence scope
bibliographic_metadata_only
id
pubmed:39976417
immutable id
pubmed:39976417@97820814b34301c26944c6ebf60883ea3af4204e1332b5c250e1901ec0ac6fdb
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
8
name
The New England journal of medicine
nlm unique id
0255562
pages
748-762
volume
392
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2025 Jun 5;392(21):2180-2181. doi: 10.1056/NEJMc2503839.
    note
    Source null
    related pmid
    40466081
    relationship
    Comment in
  2. citation
    N Engl J Med. 2025 Jun 5;392(21):2181. doi: 10.1056/NEJMc2503839.
    note
    Source null
    related pmid
    40466082
    relationship
    Comment in
outcomes validated
false
pmid
39976417
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
7f7c92fc0118eef7ca8feb8f55eb5a2e996c2b67821f317c64893a8efd21bb5e
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2025 Feb 20
precision
day
year
2025
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase III
  4. Multicenter Study
  5. Comparative Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39976417/
title
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.

Preserved source evidence · Not medical advice